SpeedWeed

AUGUST 16, 2021

Lepp was one of the industry’s greatest advocates, leaving his mark as one of many who suffered in prison as a result of trying to cultivate medical cannabis and help patients get access. The post Legendary Cannabis Advocate Eddy Lepp Passes Away 1952-2021 appeared first on SpeedWeed. View original article.

DEA 52

DEA Patients Therapy Cannabis 52

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

OCTOBER 4, 2021

September 30, 2021. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Access Pursuant to the Oregon Psilocybin Services Act. Access to Psilocybin Therapy Pursuant to Right to Try Laws. Kathryn Tucker.

Therapy 52

Therapy Patients Law Clinical Trials 52

Cannabis Law Report

MAY 29, 2022

In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5] DEA and the Controlled Substances Act.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

NOVEMBER 6, 2023

Around 12 marijuana-related bills were proposed in the 2021 Legislative Session. The Act aimed to provide patients access to smokable flower for 15 medical conditions. This progressive legislation, once implemented, means a brand new slew of patients will have access to cannabis medicine. Like Idaho, CBD with less than.3%

Legalization 117

Legalization Recreational THC CBD 117

Cannabis Law Report

JULY 20, 2021

(GEO), a leading manufacturer and distributor of premium certified organic soils and nutrients specifically designed to optimize the purity and yield of cannabis and hemp cultivation, will close its Regulation A+ crowdfunding raise this Friday, July 23, 2021 at 11:59 pm. ABOUT SEEDINVEST.

DEA 98

DEA Cultivation Access Hemp 98

Cannabis Law Report

JULY 9, 2021

In June 2021, similar measures were passed in Connecticut and Texas, where medical research on psilocybin is now also legal on a statewide level. Joyce Cutler, Texas the Latest State to Legalize Psychedelic Medical Research, BLOOMBERG LAW (June 23, 2021), available at [link]. Drug Enforcement Agency (“DEA”). 21-70544, Dkt.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

DECEMBER 15, 2021

13, 2021 /CNW/ – Havn Life Sciences Inc. (CSE: The importation of the naturally derived psilocybin into California was completed after the Company’s supply partner Mycrodose Therapeutics was granted an import license from the United States Drug Enforcement Administration (DEA). VANCOUVER, BC , Dec.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

Cannabis Law Report

JUNE 16, 2021

Hemp-derived Delta-8 THC is having a big moment in 2021 in terms of popularity and, most recently, in terms of concerns over legality, safety, and accuracy. If you feel like you’ve been catching a lot of Delta-8 THC content in the media lately, those aren’t just your social media apps hacking your brain.

THC 117

THC Hemp Media Data 117

Cannabis Law Report

JULY 23, 2021

On Wednesday, July 14, 2021 Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) released draft legislation titled the Cannabis Administration and Opportunity Act. Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF).

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

FEBRUARY 28, 2022

Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. 11, 2021), [link] [ [link] ]; Danielle Schlosser & Thomas R.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

JULY 28, 2022

Colorado could decriminalize the personal use and possession of certain psychedelic plants and fungi, including “magic mushrooms,” and create a Natural Medicine Access Program, according to a voter initiative on the November ballot. Oregon, two years ago, became the first state to legalize psilocybin with the approval of Measure 109.

Legalization 52

Legalization Decriminalization Food Safety 52

Canna Law Blog

MARCH 21, 2022

Drug Enforcement Agency (DEA) reported that the federalization of hemp would result in hemp shielding criminal activities. So, it seems the hemp moratoriums may not force growers in counties that declare states of emergency related to cannabis to cease operating.

Hemp 74

Hemp DEA Conditions Agriculture 74

Cannabis Law Report

DECEMBER 21, 2021

Numinus also made important alliances in 2021, particularly with the Multidisciplinary Association for Psychedelic Studies (MAPS) on its compassionate access trial for MDMA-assisted therapy. It was officially listed on the NYSE in August and granted a DEA schedule I manufacturing license in November.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

JANUARY 13, 2022

1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. 14, 2021, alert ). 1, out-of-state medical marijuana patients may access Arkansas’ program to purchase cannabis for up to 90 days. 2, 2021, the Kansas Office of the Attorney General released Attorney General Opinion No.

Dispensary 52

Dispensary Law Concentrates Patients 52

Cannabis Law Report

NOVEMBER 11, 2021

11 November 2021. On November 3, 2021, New York’s Cannabis Control Board (CCB) held its third public meeting during which it made additional progress in developing the regulatory landscape contemplated by the Marijuana Regulation and Taxation Act (MRTA). by Joseph W. Lippes Mathias Wexler Friedman.

Programs 52

Programs Hemp Supply Chain Seed-To-Sale 52

Cannabis Law Report

JUNE 1, 2021

Canopy Growth Reports Fourth Quarter and Fiscal Year 2021 Financial Results. Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses. Fourth Quarter Fiscal 2021 Financial Summary. (in Fiscal Year 2021 Financial Summary. (in Net revenue. 2,800) bps.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

SEPTEMBER 23, 2021

The FDA and CDC each issued warning notices to the public regarding delta-8 THC products on September 14, 2021, many of which are marketed as hemp products (and include some non-obvious references to other novel cannabinoids that may have similar effects and marketing).

THC 52

THC Concentrates Pets DEA 52

Dykema (Cannabis Law Blog)

SEPTEMBER 20, 2021

Limits on who could obtain licenses prior to December 6, 2021, (e.g., These licensees must secure registration from the DEA within 90 days of being issued their MRA license. MMFLA licensees) would be deleted.

Events 63

Events Education Consumption DEA 63

Cannabis Law Report

NOVEMBER 2, 2021

Oracle wrote 21 October 2021. The investigation covered a lot of important ground, but the main results concern the levels of delta-9 THC in each product, the inaccuracy of the labeling, how easily minors can get access to products and whether companies test for impurities. Michigan (comes into effect October 2021). Methodology.

THC 96

THC CBD Legalization Vaping 96

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp.

Research and Development 117

Research and Development Education Agriculture Patients 117

Canna Law Blog

NOVEMBER 6, 2021

Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. But only if it is made affordable and accessible. That power is typically delegated to the DEA. Psilocybin’s federal status as a Schedule I controlled substance is to blame.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

The Herb Collective

JUNE 25, 2018

"Every year, about 98% of all of the grass removed by the DEA's "Domestic Cannabis Eradication/Suppression Program" is really hemp." billion by 2021, according to a report by Arcview Market Research. The remaining $1.1 billion was spent on abuse and addiction studies. " Hemp contains less than 1% of THC.

Marijuana 56

Marijuana Edibles Recreational Strains 56

Veriheal

AUGUST 19, 2022

” Cannabis Research Should Be Based on Real, Accessible Products. In February 2021, a lawsuit was filed against the DEA for prohibiting access for others aside from the University of Mississippi to cultivate cannabis for research purposes. Could hemp replace plastics? Yes, without a doubt. Yes, according to many.

Hemp 52

Hemp DEA Access Cultivation 52

Cannabis Law Report

APRIL 13, 2022

market presence, complementary client programming and respected clinical research capabilities allow us to accelerate our strategic growth plans and broaden access to healing and wellness.” Clinics will also offer family and couples counselling, as well as in-person and virtual group therapy for expanded access to innovative treatments.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

JUNE 9, 2021

That means no matter the potency of your product, and whether you’re traveling with gummies, a vape pen, processed flower, or even the living plants themselves, in the eyes of the law, you are officially Moving With Marijuana™ Where is recreational marijuana legal in 2021? Where is medical marijuana legal in 2021? Connecticut.

Marijuana 66

Marijuana Edibles DEA THC 66

Cannabis Law Report

MAY 28, 2022

Despite progress over the past decade, the cannabis industry still struggles to access a fundamental piece of the U.S. The cannabis industry might look like just another business for local police, where legal, but the DEA and other federal agencies have a different outlook. economy: the financial system. Source: [link].

Banking 52

Banking State Laws Law DEA 52

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) today announces its financial results for the first quarter fiscal 2022 ended June 30, 2021.

Vaping 105

Vaping Research and Development Data Business 105

Project CBD

AUGUST 23, 2023

has shrunk by 48 percent since 2021. Marketing to Minors Unlike state-regulated cannabis, this new wave of acutely intoxicating substances is easily accessible to minors. Thus, it’s reasonable to assume that, as the “hemp” product market is exploding, the agricultural market should also be booming. But the opposite is true.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD. Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 1, 2021

August 30, 2021. While these businesses must pay taxes, they are largely unbanked due to regulatory hurdles that prevent such businesses from accessing banking and other financial services. [10] FEDERAL TAXATION OF CANNABIS: A PRIMER. Source: [link]. Gordon Gray. Executive Summary. 4] The majority of U.S.

Policy 100

Policy Cannabis Treatment Law 100

The Cannigma

SEPTEMBER 12, 2021

This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. THC vs CBD.

THC 98

THC Research and Development Cannabinoids CBD 98

NORML

FEBRUARY 18, 2020

The latest offense is his recently released 2021 federal budget proposes slashing all legal protection for state medical marijuana programs and potentially jeopardizing the patients that rely on them. No patient should have to worry about losing access to cannabis treatment options. The data speaks for itself.

Marijuana 355

Marijuana DEA Programs Patients 355

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. The governor of New Mexico signed a legalization bill into law in 2021, and residents can now grow and possess cannabis, but it will not be available for retail sale until 2022.

Recreational 52

Recreational Data Cannabis DEA 52

Cannabis Law Report

AUGUST 5, 2021

Aug 4, 2021 . As everyone in the cannabis industry now knows, on July 14, 2021, Senate Majority Leader Chuck Schumer (D-NY) introduced the long awaited proposed Cannabis Administration and Opportunity Act , weighing in at 163 pages. The fate of the SAFE Banking Act to enhance banking access for cannabis companies, which Sen.

Banking 111

Banking Vaping Education DEA 111

Cannabis Law Report

JULY 14, 2021

— Ron Wyden (@RonWyden) July 14, 2021. Big companies already have access to these services, and delaying that same access for small businesses would not further the goal of fostering a more diverse and inclusive industry. July 14, 2021 Friends, Today, we are saying, “The days of federal prohibition are numbered.”

Legislation 71

Legislation Banking History Access 71

Nature's Way Medicine

FEBRUARY 12, 2021

The DEA would be mandated to approve applications for manufacturers to produce marijuana-derived, FDA-approved drugs. It is imperitive that cannabis patients are allowed to have access to firearms for self-defence and their second amendment rights. The post Cannabis News 02/12/2021 appeared first on Natures Way Medicine.

Research and Development 97

Research and Development Patients CBD DEA 97